Skip to main content
Clinical Trials/ITMCTR2100004495
ITMCTR2100004495
Recruiting
Phase 1

A randomized, controlled, multicentre clinical study of optimizing Yantiao prescription in the treatment of septic shock

Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine0 sitesTBD
ConditionsSeptic shock

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Septic shock
Sponsor
Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients aged 18\-80 years old;
  • 2\. Patients with septic shock;
  • 3\. Patients with acute attack within 3 days.

Exclusion Criteria

  • 1\. Patients with allergic constitution or allergic to known components of the drug;
  • 2\. Mental patients;
  • 3\. Subjects with intestinal obstruction caused by other causes;
  • 4\. Patients with malignant tumor;
  • 5\. The subjects who did not meet the inclusion criteria, did not use drugs according to the regulations, could not determine the efficacy or incomplete information, which affected the efficacy or safety judgment.

Outcomes

Primary Outcomes

Not specified

Similar Trials